In response to syrup contamination deaths, Telangana’s Drugs Control Administration (TGDCA) has ruled that manufacturers must conduct multi-stage testing for diethylene glycol (DEG) and ethylene glycol (EG) at every production phase.
Glimpse:
TGDCA has issued a directive requiring raw ingredients, intermediate phases, and final oral liquid products (cough syrups, tonics) to be screened via gas chromatography. Any discrepancy or negligence may invite criminal action under the Drugs & Cosmetics Act.
The Telangana Drugs Control Administration has escalated its regulatory measures amid the toxic syrup controversy. It now mandates that all oral liquid drug manufacturers perform DEG and EG screening at multiple stages from sourcing raw materials (glycerin, excipients) to final product release.
The order insists manufacturers must use only pharmacopoeial-grade suppliers and maintain in-house or validated lab capacity for gas chromatography. Finished products must not be released without passing the required chemical safety thresholds. Random inspections will be conducted, and violations may be prosecuted under both the Drugs & Cosmetics Act and criminal statutes.
Officials say this measure aims to restore public confidence, prevent further tragedies, and deter substandard manufacturing practices.
“When every drop may determine life or death, every batch must be proven safe.”
By
HB Team
Related News
